PRESS RELEASE published on 12/11/2023 at 10:00, 1 year 3 months ago Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited
PRESS RELEASE published on 11/20/2023 at 12:00, 1 year 4 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000
PRESS RELEASE published on 11/02/2023 at 11:00, 1 year 5 months ago Tryp Therapeutics Inc. Announces Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3.0 Million
PRESS RELEASE published on 10/11/2023 at 22:30, 1 year 5 months ago Tryp Therapeutics Announces Closing of Private Placement of Unsecured Convertible Debentures for Gross Proceeds of AUD$175,000
PRESS RELEASE published on 08/03/2023 at 12:00, 1 year 8 months ago Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer
PRESS RELEASE published on 08/02/2023 at 12:00, 1 year 8 months ago With Great Sadness Tryp Announces the Passing of David Tousley, Director
PRESS RELEASE published on 07/13/2023 at 12:00, 1 year 8 months ago Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 05/24/2023 at 12:00, 1 year 10 months ago Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 04/27/2023 at 12:00, 1 year 11 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Secured Convertible Debentures for Gross Proceeds of AUD$2,400,000
PRESS RELEASE published on 04/12/2023 at 22:00, 1 year 11 months ago Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
Published on 04/10/2025 at 02:30, 13 minutes ago Star Copper Completes Non-Brokered Private Placement for Proceeds of $2,500,000
Published on 04/09/2025 at 23:30, 3 hours 13 minutes ago AirIQ Announces Major Customer Win Accelerating Growth in Recurring Revenue
Published on 04/09/2025 at 22:17, 4 hours 26 minutes ago Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Published on 04/09/2025 at 22:05, 4 hours 38 minutes ago Amdocs Announces Q3F25 Investor Conference Schedule
Published on 04/09/2025 at 20:20, 6 hours 23 minutes ago Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences
Published on 04/09/2025 at 20:18, 6 hours 25 minutes ago EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG publishes preliminary key figures for the financial statements as of March 31, 2025
Published on 04/09/2025 at 19:08, 7 hours 34 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/09/2025 at 18:34, 8 hours 9 minutes ago PolyPeptide announces results of the annual General Meeting 2025
Published on 04/09/2025 at 18:02, 8 hours 41 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/09/2025 at 18:59, 7 hours 43 minutes ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 7 hours 45 minutes ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 8 hours 58 minutes ago COGELEC : 2024 full-year results and Q1 2025 revenue.
Published on 04/09/2025 at 17:40, 9 hours 3 minutes ago COGELEC : Statement on the total number of shares and voting rights.
Published on 04/09/2025 at 08:00, 18 hours 43 minutes ago Museum Studio becomes a majority shareholder in Lord Cultural Resources
